Bay Area S.F. not altering health orders after city sees nation’s first omicron COVID case By Daniel Montes | Bay City News | December 2, 2021 The nation's first reported case of the omicron variant was reported in a man returning from South Africa.
City Tracking COVID-19 in Piedmont | Nov. 30 By Exedra Staff | November 30, 2021 After a lull, we're starting to see a slight uptick in reported cases.
COVID-19 Who’s in? Who’s out? The ethics of COVID-19 travel rules By Nancy S. Jecker, Professor of Bioethics and Humanities, School of Medicine, University of Washington and Caesar Atuire, Lecturer in Philosophy, University of Ghana | The Conversation | November 30, 2021 Two bioethicists see far-reaching consequences of COVID-related travel bans that should prompt policymakers to consider not just science, but ethics, too.
COVID-19 Omicron and other coronavirus variants: What you need to know By Louis Jacobson | Politifact | November 30, 2021 A round-up of what we know so far about global efforts to manage and understand the latest variant.
COVID-19 California braces for omicron COVID variant By Emily Hoeven | CalMatters | November 29, 2021 The omicron variant does not yet appear to have entered the U.S., but California is already bracing for a surge in COVID cases.
covid The hunt for coronavirus variants: how the new one was found and what we know so far By The Conversation | November 26, 2021 The World Health Organization named the new variant "omicron" Friday and described it as a variant of concern.
COVID-19 Tattoos help some people heal as they mourn COVID losses By Heidi de Marco | Kaiser Health News | November 23, 2021 Nearly a third of Americans have tattoos, and much of that ink is some kind of memorialization.
COVID-19 Another COVID holiday: Is California in a better place this year? By Ana B. Ibarra and Hannah Getahun | CalMatters | November 23, 2021 Eighteen counties, mostly rural ones, have more hospitalized COVID-19 patients today than a year ago.
COVID-19 Success of COVID antiviral pills hinges on access to speedy and accurate tests By JoNel Aleccia | Kaiser Health News | November 22, 2021 The promising antiviral drugs to treat COVID must be given to patients within three to five days of their first symptoms.
covid An infectious disease physician explains why oral antiviral pills for COVID-19 are badly needed By Patrick Jackson, Assistant Professor of Infectious Diseases, University of Virginia | The Conversation | November 19, 2021 Two new antiviral drugs could soon be the first effective oral treatments for COVID-19 to help keep people out of the hospital.